[1]
Skelhorne-Gross, G. 2012. PPAR? ligands: Is timing the key to therapeutic vs. obesogenic effects?. Health Science Inquiry. 3, 1 (Jun. 2012), Page 51-Page 52. DOI:https://doi.org/10.29173/hsi76.